AI for Geographic Atrophy

Book free trial to see how AI can detect GA and 70+ other pathologies/biomarkers

Book Intro

Altris AI is an FDA-cleared OCT scan analysis platform, that leverages AI for geographic atrophy (GA) detection. It provides:

Detection of GA biomarkers: Hypertransmission, RPE atrophy, Neurosensory retina atrophy, EZ disruption, RPE disruption.

Measurement of area and volume for each GA biomarker

Precise calculation of the GA area by measuring the area of overlap between hypertransmission, RPE atrophy, and neurosensory retina atrophy.

Progression tracking of each bioamrekers and GA area as an overlap in mm and percentages.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA-cleared (510k).

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024

Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something. Also, Altris AI described something that I thought was worse than it was. Saved me from over-referring. Patients love to see the color-coded images which help as an educational tool and get buy-in on the treatment plan which helps compliance.

1 Feb, 2024

Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023

Make informed decisions based on objective insights.
Leverage the power of the most precise GA detection.

Altris AI offers standardized and reproducible examination with accurate volumetric and area measurements down to micrometers.

Analyze the overlap of GA biomarkers.

Determine GA area precisely.

See GA-fovea distance and macular coverage.

Track pathological changes over time.

How Altris AI works?

And what's the value of using Artificial intelligence for Geographic Atrophy

Altris AI is a web platform created by retina experts for all eye care specialists and clinicians.

We’ve collected millions of OCT scans, and our team graphically labeled thousands of them to create the Altris AI system that can:

Detect over 70 pathologies and biomarkers, including GA biomarkers.

Measure and track pathological changes across multiple examinations.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Clinical Research

What you get with Altris AI:

Accelerate ophthalmic drug trial with AI
Detect GA and its biomarkers ( as well as 70+ retinal pathologies and biomarkers)
Track the progression of biomarkers to assess drug efficiency
Enroll the right patients based on fast biomarkers detection
Reduce costs associated with manual scan review with automated analysis
Reduce human made errors to the minimum

For Eye Care

We support you through the whole way

14 Days of Free Trial to see the value
Support during the whole trial period
Early glaucoma assessment module access
CE-certified, GDPR, HIPAA compliant, FDA clearance
Integration support with any EHR, EMR system.
Access to the whole functional during trial